MedPath

Merck Sharp & Dohme Corp

Merck Sharp & Dohme Corp logo
🇨🇱Chile
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1.2k

Active:1229
Completed:11

Trial Phases

4 Phases

Phase 1:971
Phase 2:3
Phase 3:5
+1 more phases

Drug Approvals

2

NMPA:1
PHILIPPINES:1

Drug Approvals

Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58)Vaccine

Product Name
九价人乳头瘤病毒疫苗(酿酒酵母)
Approval Number
S20180009
Approval Date
Apr 28, 2018
NMPA

Clinical Trials

Distribution across different clinical trial phases (983 trials with phase data)• Click on a phase to view related trials

Phase 1
971 (98.8%)
Phase 3
5 (0.5%)
Not Applicable
4 (0.4%)
Phase 2
3 (0.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.